A hemolysis assay is a crucial test used to evaluate the compatibility of nanomaterials with blood cells, specifically red blood cells (RBCs). This assay measures the extent of hemolysis, or the destruction of RBCs, when they are exposed to nanoparticles. The test helps to determine the safety and biocompatibility of nanomaterials intended for biomedical applications such as drug delivery, imaging, and diagnostics.
